Shaolin Capital Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Shaolin Capital Management’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50,000	Closed	-$44K	–	1024
2022 Q1	$44K	Sell	50,000 -105,839	-68%	-$135K	﹤0.01%	796
2021 Q4	$319K	Buy	+155,839	New	+$238K	0.01%	531

Other funds holding ROIVW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Shaolin Capital Management's ROIVW Position: Q2 2022 in Review

Shaolin Capital Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q2 2022, closing a stake of 50,000 shares — an estimated $44K sold.

Shaolin Capital Management first reported a position in ROIVW in Q4 2021 and held it in 2 quarters. The position peaked at $319K in Q4 2021. 31 funds tracked by Wall St. Rank hold ROIVW as of Q2 2022.

Shaolin Capital Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q2 2022 after selling out during the quarter.
Shaolin Capital Management sold 50,000 Roivant Sciences Ltd. Warrant shares in Q2 2022, an estimated $44K.
Shaolin Capital Management first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 2 quarters.
Shaolin Capital Management's Roivant Sciences Ltd. Warrant position peaked at $319K in Q4 2021.
31 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q2 2022.

Based on Shaolin Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.